Temporal Interference Stimulation Treatment in Patients With Cognitive Impairment
NCT: NCT07643363 · RECRUITING
Brief Summary
This study aims to evaluate the efficacy and safety of temporal interference stimulation (TIS), a non-invasive neuromodulation technique, in improving cognitive function in patients with cognitive impairment. TIS uses two high-frequency currents applied transcranially, which intersect within the brain to generate a low-frequency modulation field. This technique selectively modulates deep brain regions while minimizing the stimulation of superficial cortical layers. Participants will undergo individualized MRI-based modeling to determine the optimal electrode placement and stimulation parameters. The intervention consists of 10 stimulation sessions over a period of 14 days, using either active TIS or sham stimulation. Cognitive assessments, EEG recordings, and functional MRI scans will be conducted at baseline; 5 days after intervention initiation; at the end of the 10-day intervention; and during follow-up assessments at 4 weeks, 8 weeks, and 12 weeks post-intervention to evaluate both immediate and long-term effects on cognitive performance and neural activity. The study aims to determine whether TIS can serve as a feasible and effective neuromodulation strategy for individuals with cognitive impairment.
Frequently Asked Questions
What is Temporal Interference Stimulation Treatment in Patients With Cognitive Impairment?
Temporal Interference Stimulation Treatment in Patients With Cognitive Impairment is a clinical trial registered under NCT07643363. Current status: RECRUITING.
What is the status of NCT07643363?
The current status of NCT07643363 (Temporal Interference Stimulation Treatment in Patients With Cognitive Impairment) is: RECRUITING.
When did Temporal Interference Stimulation Treatment in Patients With Cognitive Impairment start?
Temporal Interference Stimulation Treatment in Patients With Cognitive Impairment started on 2026-07-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.